0002019160-24-000001.txt : 20240412 0002019160-24-000001.hdr.sgml : 20240412 20240411192703 ACCESSION NUMBER: 0002019160-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240411 EFFECTIVENESS DATE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sequelae, Inc. CENTRAL INDEX KEY: 0002019160 ORGANIZATION NAME: IRS NUMBER: 922164200 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510405 FILM NUMBER: 24839682 BUSINESS ADDRESS: STREET 1: 80 S 8TH ST #3100 CITY: MINNEAPOLIS STATE: MN ZIP: 55402 BUSINESS PHONE: 763-442-7383 MAIL ADDRESS: STREET 1: 80 S 8TH ST #3100 CITY: MINNEAPOLIS STATE: MN ZIP: 55402 D 1 primary_doc.xml X0708 D LIVE 0002019160 Sequelae, Inc. 80 S 8TH ST #3100 MINNEAPOLIS MN MINNESOTA 55402 763-442-7383 DELAWARE None None Corporation true 2023 Ken Ehlert 655 Bushaway Road Wayzata MN MINNESOTA 55391 Executive Officer Director Rushika Fernandopulle 46 Mount Vernon St. Unit 1 Cambridge MA MASSACHUSETTS 02140 Director Amy Schulman 130 Furman Street S-404 Brooklyn NY NEW YORK 11201 Director David Wichmann 3925 W 50th St. Suite 200 Edina MN MINNESOTA 55424 Director Albert Zimmerli 8405 S Robidoux Road Sandy UT UTAH 84093 Director Gregory Johnson 10367 N 6900 W Highland UT UTAH 84003 Executive Officer Mark Pollmann 5625 105th Ave N Brooklyn Park MN MINNESOTA 55443 Executive Officer Mark Briesacher 1776 Park Ave Ste 4 PMB 445 Park City UT UTAH 84060 Executive Officer Shiraz Fagan PO Box 2187 Rancho Santa Fe CA CALIFORNIA 92067 Executive Officer Mike Christy 3024 Fountain Way Shakopee MN MINNESOTA 55379 Executive Officer Other Technology Decline to Disclose 06b false 2023-04-18 false true true false 00 60000000 60000000 0 The $60,000,000 is in connection with a SAFE offering and although no actual amount sold, there is no remaining offering amount to be sold. false 7 0 0 1800000 true The estimate is $1,800,000 for one year of salary for all the officers. false Sequelae, Inc. Gregory Johnson Gregory Johnson Chief Financial Officer 2024-04-11